Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4

Conditions

Brain Neoplasms 19Breast Neoplasms 14Glioblastoma 4Squamous Cell Carcinoma of Head and Neck 3Salivary Gland Neoplasms 3Neoplasm Metastasis 3Esthesioneuroblastoma, Olfactory 3Stomach Neoplasms 2Neoplasms 2Meningeal Neoplasms 2Meningeal Carcinomatosis 2Head and Neck Neoplasms 2Glioma 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Bile Duct Neoplasms 2Astrocytoma 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms, Unknown Primary 1Liver Neoplasms 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Appendiceal Neoplasms 1

Interventions

Temozolomide 405Radiotherapy 202Bevacizumab 157Radiation 80Magnetic Resonance Spectroscopy 77Lomustine 49Surgical Procedures, Operative 45Carmustine 41pembrolizumab 40Irinotecan 38Nivolumab 32Specimen Handling 28Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Drug Therapy 22Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15Blood Specimen Collection 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13Ipilimumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Glioblastoma × Capecitabine × CNS × Clear all
NCT02669173 2026-02-23

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Case Comprehensive Cancer Center

Phase 1 Completed
12 enrolled
CNS

Brain Neoplasms, Glioblastoma, Recurrence

NCT03213002 2025-04-09

CAPTEM

Northwell Health

Phase 1/2 Recruiting
67 enrolled
CNS

Brain Neoplasms, Glioblastoma, Neoplasms

NCT00717197 2013-07-02

Study of Capecitabine to Treat Recurrent High Grade Gliomas

University of Florida

Phase 2 Completed
30 enrolled 7 charts
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT00504660 2012-01-11

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

M.D. Anderson Cancer Center

Phase 2 Completed
75 enrolled 8 charts
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡